1.
Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
2.
Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
The health and economic effects of HPV DNA screening in The Netherlands
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model‐based cost‐effectiveness
Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20‐year cohort study in all Dutch liver transplant units